Nearly every pregnancy in the United States includes a glucose screening, and the format surprises people: a measured sweet drink followed by timed blood draws. The design follows from what is being measured.
Pregnancy changes insulin response by design
The placenta produces hormones that reduce the body's sensitivity to insulin, which raises circulating glucose available to the developing fetus.
This is a normal adaptation, and most pregnancies compensate by increasing insulin production. Gestational diabetes describes the situation where that compensation is insufficient.
Because the change is driven by placental hormones that increase as pregnancy advances, screening is timed to the window where the demand is high enough to reveal it.
A challenge test measures response, not baseline
A single fasting glucose measurement describes a resting state. The relevant question is how the system handles a load, which requires supplying one.
The screening drink delivers a standardized amount of glucose so that everyone's response is measured against the same input. Timing of the draw is part of the standardization.
This is why the instructions about fasting, timing and remaining at the clinic matter. Deviating from them changes what the result means.
Screening and diagnosis are separate steps
In the commonly used two-step approach, an initial screen identifies those who need a longer confirmatory test rather than establishing a diagnosis on its own.
A confirmatory test involves fasting, a larger glucose load and multiple timed draws. A one-step approach is also used, and professional bodies differ on which they prefer.
An abnormal screen is therefore common and does not by itself indicate gestational diabetes. It indicates that the second test is warranted.
Why the condition is watched rather than ignored
Elevated maternal glucose crosses the placenta and prompts increased fetal insulin production, which affects fetal growth patterns.
Management is therefore aimed at keeping glucose within a target range, and the specific approach is determined by the treating clinician for the individual pregnancy.
Gestational diabetes also carries implications for later health, which is why postpartum follow-up testing is generally recommended after the pregnancy ends.
Thresholds and protocols are not universal
Diagnostic criteria have been debated among professional organizations, and different thresholds are in use in different settings.
Practices also differ on whether some patients are screened earlier based on risk factors identified at the first prenatal visit.
Because criteria, timing and management vary and change, the obstetric provider managing the pregnancy is the appropriate source for what applies to a particular person.